[Plasma glucose, insulin and increased serum levels during continuous infusion of glucose in low dosages]. 1979

M Marshall, and F Heigenhauser, and N Zöllner

Metabolic reactions during long-time intravenous infusion of glucose in dosages according to basal energy requirements of man were investigated. Infusion of 0.2-0.4 g glucose/kg body weight/h led to the typical behaviour of blood glucose with an initial peak and a subsequent steady state. The steady state was dose-dependent and always higher than the starting value. Insulin always rose significantly with increasing scattering of the individual values with higher glucose loads. With 0.1 g glucose/kg/h, the steady state of blood glucose, after a minimal initial peak, was lower than the starting value, and no change of insulin in the peripheral venous blood could be observed. Free fatty acid levels initially always decreased, but rose again under low glucose loads (0.1 and 0.2g/kg/h). In all experiments, with an increase of insulin, a decrease of serum potassium was found. Sodium, calcium, bilirubin, creatinine and urea-N did not show any typical changes.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009751 Nutritional Requirements The amounts of various substances in food needed by an organism to sustain healthy life. Dietary Requirements,Nutrition Requirements,Dietary Requirement,Nutrition Requirement,Nutritional Requirement,Requirement, Dietary,Requirement, Nutrition,Requirement, Nutritional,Requirements, Dietary,Requirements, Nutrition,Requirements, Nutritional
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Marshall, and F Heigenhauser, and N Zöllner
January 1979, Diabetes care,
M Marshall, and F Heigenhauser, and N Zöllner
March 1983, The Journal of laboratory and clinical medicine,
M Marshall, and F Heigenhauser, and N Zöllner
September 1989, Masui. The Japanese journal of anesthesiology,
M Marshall, and F Heigenhauser, and N Zöllner
January 1964, Medicina experimentalis : International journal of experimental medicine,
M Marshall, and F Heigenhauser, and N Zöllner
June 2003, Journal of thrombosis and haemostasis : JTH,
M Marshall, and F Heigenhauser, and N Zöllner
January 1995, The American journal of physiology,
M Marshall, and F Heigenhauser, and N Zöllner
July 1968, The Journal of clinical endocrinology and metabolism,
M Marshall, and F Heigenhauser, and N Zöllner
December 2014, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
Copied contents to your clipboard!